09:18 AM EST, 11/11/2025 (MT Newswires) -- Inovio Pharmaceuticals ( INO ) said Tuesday it priced its underwritten public offering of about 13.2 million shares at $1.90 per share, expecting to raise gross proceeds of about $25 million.

Underwriters were granted a 30-day option to purchase up to 2 million additional common shares, the biotechnology company said.

The offering is set to close on Wednesday, Inovio Pharmaceuticals ( INO ) said.

Shares of the company were down 7% in recent Tuesday premarket activity.